Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT : 13 years' experience in a single institute

Author

HOU, H-A^{1 2} ; YAO, M² ; LIN, K-H³ ; HSIAO, C-H⁴ ; LIN, C-W⁴ ; CHEN, Y-C^{2 5} ; TANG, J-L² ; CHEN, Y-K² ; KO, B-S² ; HUANG, S-Y² ; TIEN, H-F² ; CHANG, H-H³ ; LU, M-Y³ ; LIN, T-T³
[1] Department of Internal Medicine, National Taiwan University Hospital Yun-lin Branch, College of Medicine, National Taiwan University, Yun-lin County, Taiwan, Province of China
[2] Department of Internal Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, Province of China
[3] Department of Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, Province of China
[4] Department of Pathology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, Province of China
[5] Department of Laboratory Medicine, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan, Province of China

Source

Bone marrow transplantation (Basingstoke). 2009, Vol 43, Num 4, pp 315-321, 7 p ; ref : 33 ref

CODEN

BMTRE9

ISSN

0268-3369

Scientific domain

Medical oncology; Graft, transplantation; Hematology

Publisher

Nature Publishing Group, Basingstoke

Publication country

United Kingdom

Document type

Article

Language

English

Author keyword

hematopoietic SCT post transplant lymphoproliferative disease pulmonary involvement rituximab

Keyword (fr)

Anticancéreux Anticorps monoclonal Homogreffe Hématologie Immunodépresseur Immunomodulateur Immunothérapie Poumon Pronostic Rituximab Syndrome lymphoprolifératif posttransplantation Syndrome lymphoprolifératif Traitement Anti-CD20 Antigène CD20 Appareil respiratoire Greffe Hémopathie

Keyword (en)

Antineoplastic agent Monoclonal antibody Homograft Hematology Immunosuppressive agent Immunomodulator Immunotherapy Lung Prognosis Rituximab Posttransplant lymphoproliferative disorder Lymphoproliferative syndrome Treatment Respiratory system Graft Hemopathy

Keyword (es)

Anticanceroso Anticuerpo monoclonal Homoinjerto Hematología Inmunodepresor Inmunomodulador Inmunoterapia Pulmón Pronóstico Rituximab Síndrome linfoproliferativo postrasplante Linfoproliferativo síndrome Tratamiento Aparato respiratorio Injerto Hemopatía

Classification

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B19 Hematologic and hematopoietic diseases / 002B19B Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis

Pascal

002 Biological and medical sciences / 002B Medical sciences / 002B27 Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy / 002B27D Transfusions. Complications. Transfusion reactions. Cell and gene therapy / 002B27D02 Bone marrow, stem cells transplantation. Graft versus host reaction

Discipline

Anaesthesia. Reanimation. Transfusion. Cell therapy and gene therapy Blood diseases

Origin

Inist-CNRS

Database

PASCAL

INIST identifier

21304410

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS